What Happens Next as F.D.A., C.D.C. Weigh Covid Shots for Childrennews2021-10-26T12:40:51+00:00October 26th, 2021|The New York Times|
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shotsnews2021-10-18T23:32:29+00:00October 18th, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11news2021-10-08T00:24:12+00:00October 8th, 2021|The New York Times|
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shotnews2021-10-04T17:16:18+00:00October 4th, 2021|The New York Times|
Phony Diagnoses Hide High Rates of Drugging at Nursing Homesnews2021-09-11T16:37:07+00:00September 11th, 2021|The New York Times|
America Desperately Needs a Much Better F.D.A.news2021-09-02T15:02:58+00:00September 2nd, 2021|The New York Times|
How an Unproven Alzheimer’s Drug Got Approvednews2021-07-20T02:12:00+00:00July 20th, 2021|The New York Times|
U.S. Officials Press Pfizer for More Evidence of Need for Booster Shotnews2021-07-13T03:14:09+00:00July 13th, 2021|The New York Times|
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccinenews2021-07-13T02:28:00+00:00July 13th, 2021|The New York Times|
